000128017 001__ 128017
000128017 005__ 20240711085510.0
000128017 0247_ $$2doi$$a10.1007/s11259-023-10190-2
000128017 0248_ $$2sideral$$a135178
000128017 037__ $$aART-2024-135178
000128017 041__ $$aeng
000128017 100__ $$aGiner, Jacobo
000128017 245__ $$aSeroprevalence of anti-SARS-CoV-2 antibodies in household domestic ferrets (Mustela putorius furo) in Spain, 2019–2023
000128017 260__ $$c2024
000128017 5060_ $$aAccess copy available to the general public$$fUnrestricted
000128017 5203_ $$aSARS-CoV-2 is the causal agent of Coronavirus Disease 2019 (COVID-19) in humans that emerged in late 2019. This virus is able to infect humans and different animal species. Among pets, cats and ferrets are more susceptible to be infected by the SARS-CoV-2. Epidemiological studies are an important tool to provide information under natural conditions of exposure to SARS-CoV-2 virus. In comparison to cats, limited epidemiological studies have been performed in domestic ferrets (Mustela putorius furo) reporting the presence of antibodies in this species. This study analysed the presence of anti-SARS-CoV-2 antibodies in 432 cliend-owned ferrets from different geographical areas of Spain during the different waves of COVID-19 outbreaks from December 2019 to May 2023 (42 months). For this purpose, anti-SARS-CoV-2 antibodies were detected by an enzyme-linked immunosorbent method (ELISA) using the receptor binding domain (RBD) of Spike antigen and confirmed by serum virus neutralization assay. Eighteen of the 432 ferrets included were seroreactive by the in-house ELISA (4.17%, 95% Confidence Interval (CI): 2.65–6.49). In this sense, the wave of COVID-19 with the higher number of seropositive ferrets occurred during the seventh wave when the different Omicron subvariants were the dominant virus variants. Our results suggest that the risk of SARS-CoV-2 transmission in domestic ferrets in natural conditions is low. Further research is need to evaluate the potential risk of transmission of SARS-CoV-2 from human to pets.
000128017 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000128017 592__ $$a0.483$$b2023
000128017 593__ $$aVeterinary (miscellaneous)$$c2023$$dQ2
000128017 593__ $$aMedicine (miscellaneous)$$c2023$$dQ3
000128017 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000128017 700__ $$0(orcid)0000-0001-5816-6167$$aLebrero, María Eugenia$$uUniversidad de Zaragoza
000128017 700__ $$aTrotta, Michele
000128017 700__ $$aRueda, Pablo
000128017 700__ $$aVilalta, Laura
000128017 700__ $$0(orcid)0000-0003-2957-1379$$aVerde, Maite$$uUniversidad de Zaragoza
000128017 700__ $$0(orcid)0000-0002-3122-9401$$aHurtado-Guerrero, Ramón
000128017 700__ $$0(orcid)0000-0003-0154-0730$$aPardo, Julián$$uUniversidad de Zaragoza
000128017 700__ $$0(orcid)0000-0002-7822-6646$$aLacasta, Delia$$uUniversidad de Zaragoza
000128017 700__ $$aSantiago, Llipsy
000128017 700__ $$0(orcid)0000-0002-9730-2210$$aArias, Maykel
000128017 700__ $$aPeña-Fresneda, Natacha
000128017 700__ $$aMontesinos, Andrés
000128017 700__ $$aPérez, María D.
000128017 700__ $$0(orcid)0000-0002-2557-4890$$aFernández, Antonio$$uUniversidad de Zaragoza
000128017 700__ $$0(orcid)0000-0001-6209-4282$$aVillanueva-Saz, Sergio$$uUniversidad de Zaragoza
000128017 7102_ $$11011$$2566$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Inmunología
000128017 7102_ $$11009$$2617$$aUniversidad de Zaragoza$$bDpto. Patología Animal$$cÁrea Medicina y Cirugía Animal
000128017 773__ $$g48 (2024), 533–540$$pVet. res. commun.$$tVeterinary Research Communications$$x0165-7380
000128017 8564_ $$s659276$$uhttps://zaguan.unizar.es/record/128017/files/texto_completo.pdf$$yVersión publicada
000128017 8564_ $$s2071242$$uhttps://zaguan.unizar.es/record/128017/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000128017 909CO $$ooai:zaguan.unizar.es:128017$$particulos$$pdriver
000128017 951__ $$a2024-07-11-08:52:26
000128017 980__ $$aARTICLE